AntineoplasticsPremature ovarian failure: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2012年 / 1404卷 / 1期

关键词：

Estradiol; Etoposide; Irinotecan; Vincristine; Follicle Stimulate Hormone;

D O I：

10.2165/00128415-201214040-00021

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：8 / 8

相关论文

共 50 条

[1] AntineoplasticsPremature ovarian failure: case report
Reactions Weekly, 2019, 1757 (1) : 40 - 40
[2] AntineoplasticsPremature ovarian insufficiency: case report
Reactions Weekly, 2017, 1641 (1) : 34 - 34
[3] AntineoplasticsPremature ovarian insufficiency: case report
Reactions Weekly, 2017, 1678 (1) : 19 - 19
[4] AntineoplasticsPremature ovarian failure: 2 case reports
Reactions Weekly, 2019, 1734 (1) : 55 - 55
[5] Antithymocyte-globulin/antineoplasticsPremature ovarian failure: 19 case reports
Reactions Weekly, 2014, 1515 (1) : 32 - 33
[6] MefloquineFirst report of ovarian failure: case report
Reactions Weekly, 1999, 735 (1) : 9 - 9
[7] CyclophosphamidePremature ovarian failure: case report
Reactions Weekly, 2019, 1758 (1) : 121 - 121
[8] AntineoplasticsPrecocious ovarian failure: case report
Reactions Weekly, 2015, 1534 (1) : 21 - 21
[9] CyclophosphamidePremature ovarian failure: case report
Reactions Weekly, 2022, 1896 (1) : 155 - 155
[10] CyclophosphamidePremature ovarian failure: case report
Reactions Weekly, 2020, 1791 (1) : 82 - 82

← 1 2 3 4 5 →